行情

AXGN

AXGN

Axogen Inc.
NASDAQ

实时行情|Nasdaq Last Sale

14.31
-0.71
-4.73%
盘后: 14.31 0 0.00% 16:41 01/17 EST
开盘
15.13
昨收
15.02
最高
15.13
最低
14.18
成交量
35.29万
成交额
--
52周最高
25.84
52周最低
10.91
市值
5.65亿
市盈率(TTM)
-20.4458
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AXGN 新闻

  • 沪指震荡上扬 中国央行4天投放1.1万亿
  • 新浪财经.51分钟前
  • 英媒刊文:生产率下滑正困扰新兴经济体
  • 参考消息.1小时前
  • 戈恩为何决定逃亡?日媒揭秘:或因听闻审理将延期
  • 中国新闻网.1小时前
  • 日媒:戈恩从日本逃往黎巴嫩或因听闻审理将延期
  • 新京报网.1小时前

更多

所属板块

先进医疗设备和技术
+0.57%
医疗设备和用品
+0.29%

热门股票

名称
价格
涨跌幅

AXGN 简况

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.
展开

Webull提供Axogen Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。